Plantibodies, also known as plant-derived antibodies, are an emerging class of biologics that are produced from plants. They are composed of recombinant protein fragments, which are generated from plant expression systems. Plantibodies have a number of advantages over traditional animal-sourced antibodies. They are cost-effective and easier to manufacture, as they do not require animal serum, and they are also less likely to cause adverse reactions in patients due to their low immunogenicity. Plantibodies are also highly stable and can be produced at high yields, making them an attractive alternative to traditional antibodies. Plantibodies have been studied for a variety of therapeutic and diagnostic applications, such as cancer immunotherapies, infectious disease diagnostics, and allergy treatments. In addition, they are also being developed for use in vaccines and crop protection, making them a versatile and promising tool for medical and agricultural research.
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Plant Growth-Promoting Rhizobacteria (PGPR) improve maize development under saline stress conditions: A sustainable biotechnology approach
Abdul Khalil Gardezi, Colegio de Posgraduados, Mexico